Liminal announced on September 2nd, 2026, the launch of Liminal Prime, a new enterprise software suite aimed at institutional clients seeking principal OTC dealing and stablecoin liquidity connectivity. This launch expands Liminal’s existing infrastructure, which includes institutional digital asset wallet and key-management solutions.
Liminal Prime comprises three distinct products: White-Glove OTC, Electronic OTC (eOTC), and Bridge. These are designed to provide trading and liquidity access while integrating with established institutional governance and compliance frameworks. According to Liminal, the suite addresses a client-identified gap for trading and liquidity infrastructure that operates within existing compliance structures.
Product Details:
- White-Glove OTC: Intended for high-value, complex, and time-sensitive block trades, facilitated by a dedicated dealing desk.
- Electronic OTC (eOTC): Offers both GUI and API-driven access to streaming and firm quotes for high-frequency digital asset transaction flows.
- Bridge: A technology platform enabling institutions to request quotes from and trade directly with liquidity providers they have onboarded.
Liminal stated that each product functions as an independent module, allowing for separate licensing and deployment, providing flexibility based on operational and regulatory needs. These products were developed through direct engagement with Liminal’s client base, including licensed exchanges, payment companies, financial institutions, and digital asset businesses.
Liminal’s existing infrastructure has processed over US$100 billion in on-chain transactions across more than 20 blockchain networks for institutions in over 12 countries. Liminal Prime is positioned to support the next phase of institutional adoption, focusing on trading, liquidity access, and operational efficiency.
Regulatory Considerations:
Liminal noted that White-Glove OTC and eOTC are restricted and unavailable in the UAE, India, Singapore, and Taiwan. The availability of the Bridge product is subject to local regulatory requirements, though specific details were not provided. Liminal emphasizes that users are solely responsible for ensuring compliance with all local regulations before accessing its services.
Liminal clarified its role in these offerings. For White-Glove OTC and eOTC, Liminal acts as the principal counterparty for its own account on every trade. For the Bridge product, Liminal is not the counterparty, does not operate an exchange or brokerage, and takes no custody of assets; its role is limited to routing quote requests and supporting communication between the institution and its chosen liquidity provider, with the trade and settlement occurring directly between those parties off-platform.
Across all three products, Liminal Prime offers configurable reporting, audit-ready workflows, and integration with Liminal’s existing wallet and key-management infrastructure. The products support multiple blockchain networks and major digital asset pairs, designed to provide the transparency, governance, and operational controls required by institutions.
Liminal Prime represents the initial phase of a broader infrastructure strategy, with the company planning to continue developing its product offerings as institutional participation in digital asset markets grows. The company’s objective is to serve as a trusted infrastructure partner for licensed institutions throughout their digital asset operations.
Why This Matters
The materials describe a narrow update: Liminal has launched Liminal Prime, an enterprise software suite offering principal OTC dealing and LP connectivity for institutional clients. The availability of Bridge is subject to local regulatory requirements.
Broader Context
Source materials place the announcement in this context: Liminal is a provider of institutional digital asset wallet and key-management infrastructure.









